Table 5.

Low-resource strategies for REMG accrual in cancer research.

Strategy	References/examples
Launch awareness campaigns to raise awareness of cancer clinical trials to patients and support physician recruitment efforts	Be the Breakthrough (FCCC); Count Me In (UTSW)
Share recruitment materials with patients and care partners which are health literate and linguistically accessible (i.e., in plain language, appropriately formatted, and in the languages of desired participant population)	Recommended by all centers [27]. Stand Up To Cancer campaign [28]
Ask Patients and community leaders (including Primary Care Physicians) for input on questions to be answered in cancer trials and feasibility of trial implementation	Recommended by all centers
There are different types of research which can be effectively implemented: •biorepositories can be implemented more efficiently by working with the pathology team •non-interventional, cancer screening programs can be started and enabled with minimal resource requirement so that trust, process/operations and learnings can be built upon	Recommended by HFCI
Offering of clinical trials focusing on reducing treatment length as American Indian (AI) live a median of 140 miles from the cancer center in Rapid City, SD; recommended as part of the Walking Forward Program experience	Recommended by JVCI [29]
Advocate for consolidation of tests required for screening for a trial into a one-day process. The resource required is an individual designated to coordinate scheduling the necessary tests in a thoughtful manner	Recommended by WCI-EMORY
Engaging a family member or care partner in addition to the patient to serve as a second ‘set of ears’ and reinforcement regarding the trial process	Recommended by WCI-EMORY
Timing of clinical research offering to patient and consent: •the experience of the consenter and the timing of the offering from the physician provider of a clinical trial are what matter most to patient recruitment •the trial is best offered by the provider at the time of treatment discussion as being consistent with the standard of care	Recommended by all centers [30,31]

Centers: FCCC, Fox Chase Cancer Center/Temple Health (Philadelphia, PA); UTSW, Harold C. Simmons Comprehensive Cancer Center/UT Southwestern Medical Center (Dallas, TX); HFCI, Henry Ford Cancer Institute (Detroit, MI); MUSC, Hollings Cancer Center/MUSC (Charleston, SC); JVCI, John T. Vucurevich Cancer Institute/Rapid City Regional Hospital (Rapid City, SD); MDACC, MD Anderson Cancer Center/UT (Houston, TX); UCDCCC, UC Davis Comprehensive Cancer Center (Sacramento, CA); WCI-EMORY, Winship Cancer Institute/Emory (Atlanta, GA). Stand Up 2 Cancer (SU2C).